Competitive Landscapes and Lyme Disease Diagnostic Market Share
The competitive arena in 2026 is a blend of global diagnostic titans and specialized "Health-Tech" innovators. Analysis of Lyme Disease Diagnostic Market share shows that Bio-Rad Laboratories, Abbott, Roche Diagnostics, and Thermo Fisher Scientific maintain dominance through their large-scale automated lab platforms. However, "Point-of-Care" disruptors like T2 Biosystems and DiaSorin (in...
0 Comments 0 Shares 63 Views 0 Reviews